UBS AM’s ICU Medical ICUI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.3M Sell
79,421
-9,185
-10% -$1.32M ﹤0.01% 1178
2025
Q4
$12.6M Buy
88,606
+10,557
+14% +$1.41M ﹤0.01% 1032
2025
Q3
$9.36M Sell
78,049
-15,315
-16% -$1.94M ﹤0.01% 1091
2025
Q2
$12.3M Buy
93,364
+25,153
+37% +$3.41M ﹤0.01% 1255
2025
Q1
$9.47M Buy
68,211
+16,680
+32% +$2.59M ﹤0.01% 1253
2024
Q4
$8M Buy
51,531
+8,789
+21% +$1.49M ﹤0.01% 1364
2024
Q3
$7.79M Buy
42,742
+1,751
+4% +$259K ﹤0.01% 1345
2024
Q2
$4.87M Buy
40,991
+14,314
+54% +$1.51M ﹤0.01% 1504
2024
Q1
$2.86M Buy
26,677
+360
+1% +$35.8K ﹤0.01% 1507
2023
Q4
$2.62M Hold
26,317
﹤0.01% 1546
2023
Q3
$3.13M Sell
26,317
-2,542
-9% -$379K ﹤0.01% 1411
2023
Q2
$4.76M Hold
28,859
﹤0.01% 1249
2023
Q1
$4.76M Sell
28,859
-1,933
-6% -$333K ﹤0.01% 1249
2022
Q4
$4.85M Sell
30,792
-326
-1% -$49.6K ﹤0.01% 1180
2022
Q3
$4.69M Sell
31,118
-4,497
-13% -$748K ﹤0.01% 1221
2022
Q2
$5.85M Buy
35,615
+1,032
+3% +$199K ﹤0.01% 1158
2022
Q1
$7.7M Buy
34,583
+242
+0.7% +$54.2K ﹤0.01% 1171
2021
Q4
$8.15M Buy
34,341
+302
+0.9% +$70.5K ﹤0.01% 1202
2021
Q3
$7.94M Buy
34,039
+489
+1% +$103K ﹤0.01% 1173
2021
Q2
$6.9M Sell
33,550
-263
-0.8% -$54.1K ﹤0.01% 1245
2021
Q1
$6.95M Buy
33,813
+87
+0.3% +$18.4K ﹤0.01% 1209
2020
Q4
$7.23M Buy
33,726
+8,977
+36% +$1.74M ﹤0.01% 1164
2020
Q3
$4.52M Buy
24,749
+738
+3% +$139K ﹤0.01% 1192
2020
Q2
$4.43M Buy
24,011
+1,009
+4% +$200K ﹤0.01% 1165
2020
Q1
$4.64M Sell
23,002
-503
-2% -$96.8K ﹤0.01% 1070
2019
Q4
$4.4M Buy
23,505
+918
+4% +$158K ﹤0.01% 1244
2019
Q3
$3.6M Sell
22,587
-16,326
-42% -$3.25M ﹤0.01% 1342
2019
Q2
$9.8M Buy
38,913
+3,994
+11% +$926K 0.01% 966
2019
Q1
$8.36M Buy
34,919
+11,289
+48% +$2.71M 0.01% 980
2018
Q4
$5.43M Buy
23,630
+7,650
+48% +$1.89M ﹤0.01% 1068
2018
Q3
$4.52M Buy
15,980
+561
+4% +$164K ﹤0.01% 1179
2018
Q2
$4.53M Sell
15,419
-8,785
-36% -$2.4M ﹤0.01% 1186
2018
Q1
$6.11M Sell
24,204
-22,965
-49% -$5.4M ﹤0.01% 1079
2017
Q4
$10.2M Buy
47,169
+10,271
+28% +$2.08M 0.01% 921
2017
Q3
$6.86M Buy
36,898
+5,969
+19% +$1.04M 0.01% 995
2017
Q2
$5.34M Sell
30,929
-2,165
-7% -$347K 0.01% 1023
2017
Q1
$5.05M Sell
33,094
-2,865
-8% -$419K 0.01% 1012
2016
Q4
$5.3M Sell
35,959
-13,522
-27% -$1.96M 0.01% 981
2016
Q3
$6.25M Sell
49,481
-3,822
-7% -$461K 0.01% 976
2016
Q2
$6.01M Hold
53,303
0.01% 975
2016
Q1
$5.55M Buy
53,303
+8,341
+19% +$797K 0.01% 995
2015
Q4
$5.07M Buy
44,962
+35,349
+368% +$3.91M 0.01% 1069
2015
Q3
$1.05M Buy
9,613
+3,013
+46% +$322K ﹤0.01% 1702
2015
Q2
$631K Buy
6,600
+100
+2% +$9.35K ﹤0.01% 1929
2015
Q1
$605K Buy
6,500
+300
+5% +$26.2K ﹤0.01% 1878
2014
Q4
$508K Buy
6,200
+500
+9% +$38.3K ﹤0.01% 1935
2014
Q3
$366K Hold
5,700
﹤0.01% 2034
2014
Q2
$347K Hold
5,700
﹤0.01% 2094
2014
Q1
$341K Buy
5,700
+2,000
+54% +$123K ﹤0.01% 2099
2013
Q4
$236K Buy
3,700
+400
+12% +$25.7K ﹤0.01% 2291
2013
Q3
$224K Sell
3,300
-23,979
-88% -$1.71M ﹤0.01% 2272
2013
Q2
$1.97M Buy
+27,279
New +$1.8M ﹤0.01% 1225

Other funds holding ICUI

UBS AM's ICUI Position: Q1 2026 in Review

UBS AM reduced its ICU Medical (ICUI) stake by 10% in Q1 2026, selling an estimated $1.32M and leaving 79,421 shares worth $10.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1178.

UBS AM first reported a position in ICUI in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.6M in Q4 2025. 275 funds tracked by Wall St. Rank hold ICUI as of Q1 2026.

  • UBS AM held 79,421 shares of ICU Medical worth $10.3M as of Q1 2026.
  • UBS AM sold 9,185 ICU Medical shares in Q1 2026, an estimated $1.32M.
  • ICU Medical made up ﹤0.01% of UBS AM's portfolio in Q1 2026, its #1178 holding.
  • UBS AM first reported a position in ICU Medical in Q2 2013 and has held it in 52 quarters since.
  • UBS AM's ICU Medical position peaked at $12.6M in Q4 2025.
  • 275 funds tracked by Wall St. Rank held ICU Medical as of Q1 2026.

Based on UBS AM's 13F filing for Q1 2026, filed 13 May 2026.